| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,077 |
2,914 |
$155K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,963 |
5,524 |
$144K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,192 |
3,031 |
$136K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,486 |
4,221 |
$35K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,087 |
2,026 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,605 |
1,388 |
$34K |
| 86738 |
|
1,896 |
1,830 |
$28K |
| 80061 |
Lipid panel |
1,941 |
1,887 |
$26K |
| 80053 |
Comprehensive metabolic panel |
2,346 |
2,232 |
$25K |
| 86328 |
|
1,115 |
1,068 |
$20K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
373 |
341 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
595 |
573 |
$17K |
| 36415 |
Collection of venous blood by venipuncture |
1,518 |
1,441 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
950 |
915 |
$9K |
| 81000 |
|
2,536 |
2,444 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
162 |
158 |
$7K |
| 86701 |
|
690 |
667 |
$6K |
| 80074 |
|
81 |
74 |
$4K |
| 87590 |
|
141 |
141 |
$3K |
| 84439 |
|
323 |
310 |
$3K |
| 87088 |
|
280 |
267 |
$2K |
| 82274 |
|
140 |
132 |
$2K |
| 86592 |
|
372 |
357 |
$2K |
| 82043 |
|
234 |
223 |
$1K |
| 82570 |
|
263 |
248 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
158 |
150 |
$1K |
| 84436 |
|
110 |
106 |
$730.44 |
| 84479 |
|
119 |
110 |
$527.10 |
| 82607 |
|
13 |
13 |
$209.49 |
| 86695 |
|
14 |
12 |
$186.94 |
| 85730 |
|
12 |
12 |
$78.48 |
| 85610 |
|
12 |
12 |
$51.48 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
558 |
538 |
$0.00 |